50 companies

Pherecydes Pharma Société anonyme

Market Cap: €14.4m

Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.

ALPHE

€2.00

7D

2.6%

1Y

-53.6%

Valbiotis

Market Cap: €12.6m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.

ALVAL

€0.79

7D

-0.3%

1Y

-38.5%

Predilife

Market Cap: €12.1m

Designs and markets predictive tests for the occurrence of serious illnesses.

ALPRE

€3.20

7D

0%

1Y

-33.6%

Valerio Therapeutics Société anonyme

Market Cap: €10.6m

A clinical-stage biotechnology company, designs and develops novel and first-in-class DNA-decoy therapies targeting proteins in tumors and inflammatory disease processes.

ALVIO

€0.058

7D

-0.3%

1Y

-25.4%

Oncodesign Precision Medicine Société anonyme

Market Cap: €10.1m

A biopharmaceutical company, engages in the precision medicine business.

ALOPM

€0.55

7D

7.8%

1Y

-48.9%

Plant Advanced Technologies

Market Cap: €10.0m

A plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France.

ALPAT

€8.90

7D

-2.6%

1Y

-39.5%

TME Pharma

Market Cap: €9.5m

A clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany.

ALTME

€0.10

7D

4.1%

1Y

-25.2%

Aton

Market Cap: €6.4m

Operates as a bioscience company in France.

ALTAO

€0.0078

7D

2.6%

1Y

-43.5%

Quantum Genomics Société Anonyme

Market Cap: €5.0m

A healthtech company, develops of drugs to treat cardiovascular diseases.

ALQGC

€0.072

7D

0%

1Y

-8.0%

Biophytis

Market Cap: €3.6m

A clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases.

ALBPS

€0.15

7D

-8.2%

1Y

-61.9%

Coretech 5 Société anonyme

Market Cap: €1.7m

A pharmaceutical development company, engages in the development and marketing of various veterinary solutions for pets.

MLCOT

€0.13

7D

-4.4%

1Y

738.7%

GeNeuro

Market Cap: €1.4m

A clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases.

GNRO

€0.046

7D

15.5%

1Y

-40.8%

IntegraGen

Market Cap: €1.0m

Provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France.

ALINT

€0.15

7D

-15.8%

1Y

-69.9%

Neovacs

Market Cap: €80.9k

A biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France.

ALNEV

€0.17

7D

-25.9%

1Y

-100.0%

Page 2 of 2